Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis

Journal of Surgical Oncology

Volumn 93, Issue 1, 2006, Pages 36-42

  Kondo, Keisaku ^a   Muramatsu, Michiko ^a   Okamoto, Yukiko ^a   Jin, Denan ^a   Takai, Shinji ^a   Tanigawa, Nobuhiko ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiogenesis; Chymase; Gastric cancer; Mast cells

Indexed keywords

ANGIOTENSIN II; CD34 ANTIBODY; CD34 ANTIGEN; CHYMASE; GELATINASE B; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MAST CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II; CHYMASES; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; SERINE ENDOPEPTIDASES; STOMACH NEOPLASMS;

EID: 29844458158     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20394     Document Type: Article

References (36)

1. Muramatsu M, Katada J, Hayashi I, et al.: Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J Biol Chem 2000;275:5545-5552.
2. Takai S, Shiota N, Sakaguchi M, et al.: Characterization of chymase from human vascular tissues. Clin Chim Acta 1997;265: 13-20.
3. Katada J, Muramatsu M, Hayashi I, et al.: Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin- dependent pathway during angiogenesis in hamster sponge granulomas. J Pharmacol Exp Ther 2002;302: 949-956.
4. Muramatsu M, Yamada M, Takai S, et al.: Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase-angiotensin-dependent pathway in hamster sponge granulomas. Br J Pharmacol 2002;137:554-560.
5. Fang KC, Raymond WW, Lazarus SC, et al.: Dog mastocytoma cells secrete a 92-kDa gelatinase activated extracellularly by mast cell chymase. J Clin Invest 1996;97:1589-1596.
6. Fang KC, Raymond WW, Blount JL, et al.: Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem 1997;272:25628-25635.
7. Baroni C, Scelsi R: On the relationship of mast cells to various bone, cartilaginous and synovial tumours. Pathol Eur 1967;2: 382-393.
8. Jayalakshmi P, Looi LM, Arokiasamy JT: Correlation between mast cell infiltration and histopathologic factors in carcinoma of the stomach. Scand J Gastroenterol 1999;34:639-640.
9. Glowacki J, Mulliken JB: Mast cells in hemangiomas and vascular malformations. Pediatrics 1982;70:48-51.
10. Yano H, Kinuta M, Tateishi H, et al.: Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer 1999;2:26-32.
11. Egozi EI, Ferreira AM, Burns AL, et al.: Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair Regen 2003;11:46-54.
12. Yatsunami J, Aoki S, Fukuno Y, et al.: Antiangiogenic and antitumor effects of tranilast on mouse lung carcinoma cells. Int J Oncol 2000;17:1151-1156.
13. Yamada M, Ueda M, Naruko T, et al.: Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int 2001;59:1374-1381.
14. Joo YE, Rew JS, Seo YH, et al.: Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J Clin Gastroenterol 2003;37:28-33.
15. Suzuki T, Kaki H, Naya S, et al.: Recombinant human chymase produced by silkworm-baculovirus expression system: Its application for a chymase detection kit. Jpn J Pharmacol 2002;90:210-213.
16. Vartanian RK, Weidner N: Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994;144:1188-1194.
17. Schwartz LB, Bradford TR: Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem 1986;261:7372-7379.
18. Pereira PJ, Bergner A, Macedo-Ribeiro S, et al.: Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 1998;392:306-311.
19. Alter SC, Kramps JA, Janoff A, et al.: Interactions of human mast cell tryptase with biological protease inhibitors. Arch Biochem Biophys 1990;276:26-31.
20. Fajardo I, Pejler G: Human mast cell beta-tryptase is a gelatinase. J Immunol 2003;171:1493-1499.
21. Blair RJ, Meng H, Marchese MJ, et al.: Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997;99:2691-2700.
22. Terada T, Matsunaga Y: Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 2000;33:961-966.
23. Imada A, Shijubo N, Kojima H, et al.: Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 2000;15:1087-1093.
24. Takanami I, Takeuchi K, Naruke M: Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000;88:2686-2692.
25. Muramatsu M, Katada J, Hattori M, et al.: Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas. Eur J Pharmacol 2000;402:181-191.
26. Tenderenda M, Rutkowski P, Jesionek-Kupnicka D, et al.: Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index. Pathol Oncol Res 2001;7:129-134.
27. Frank BT, Rossall JC, Caughey GH, et al.: Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase. J Immunol 2001;166:2783-2792.
28. Willett WC, MacMahon B: Diet and cancer-An overview. N Engl J Med 1984;310:633-638.
29. Willett WC, MacMahon B: Diet and cancer-An overview (second of two parts). N Engl J Med 1984;310:697-703.
30. Messina MJ, Persky V, Setchell KD, et al.: Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr Cancer 1994;21:113-131.
31. Fournier DB, Erdman JW, Jr., Gordon GB: Soy, its components, and cancer prevention: A review of the in vitro, animal, and human data. Cancer Epidemiol Biomarkers Prev 1998;7:1055-1065.
32. Ware JH, Wan XS, Rubin H, et al.: Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch Biochem Biophys 1997;344:133-138.
33. Bawadi HA, Antunes TM, Shih F, et al.: In vitro inhibition of the activation of pro-matrix metalloproteinase 1 (Pro-MMP-1) and Pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman-Birk inhibitors. J Agric Food Chem 2004;52:4730-4736.
34. Maruyama R, Hatta E, Yasuda K, et al.: Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: Modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors. J Pharmacol Exp Ther 2000;294:248-254.
35. Ito LS, Inoue M, Tajima K, et al.: Dietary factors and the risk of gastric cancer among Japanese women: A comparison between the differentiated and non-differentiated subtypes. Ann Epidemiol 2003;13:24-31.
36. Nakajima S, Krishnan B, Ota H, et al.: Mast cell involvement in gastritis with or without Helicobacter pylori infection. Gastroenterology 1997;113:746-754.